Where Buyers
and Sellers Find Each Other

A Marketplace for Private Stock

Invest in Hot Startup Companies

Early Liquidity for Employees of Hot Startups

MabVax Therapeutics /Selling

Posting ID: MAB-1707159bllun

Posted On: 11/21/2012 - 3:59pm

Reply Back To Listing

MabVax Therapeutics closes a Series B round at $6.82 per share

On November 21, 2012 MabVax Therapeutics raised $5.25M in a Series B financing.